The FLUOROspeed is intended to be used as a universal diagnostic imaging system for radiographic ...

FDA Device Recall #Z-0317-2025 — Class II — September 6, 2024

Recall Summary

Recall Number Z-0317-2025
Classification Class II — Moderate risk
Date Initiated September 6, 2024
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm SHIMADZU CORPORATION MEDICAL SYSTEMS DIVISION
Location Kyoto, N/A
Product Type Devices
Quantity 30

Product Description

The FLUOROspeed is intended to be used as a universal diagnostic imaging system for radiographic and fluoroscopic studies. Using a flat detector, it can perform a range of applications including general R/F, angiography and pediatric examinations. FLUOROspeed may be used for emergency treatment on an outpatient basis, as well as for bedside examinations.

Reason for Recall

X-ray R/F system software with certain versions of the control board may occasionally fail to display images when switching from Fluoroscopy mode to Radiography mode, which may lead to the possibility of delay or cancellation of the examination.

Distribution Pattern

US Nationwide distribution in the states of CA, CT, MA, WV, OH, NY, IA, NE, MN, IL, FL, NC, HI, LA, MD, MT, WA, AR, TX, TN, CO.

Lot / Code Information

UDI-DI: 04540217065271. Serial Numbers: MQ493E3E3001, MQ493E3E3002, MQ493E3D6002, MQ493E3D5001, MQ493E3D8002, MQ493E3E1002, MQ493E3D4002, MQ493E3D6003, MQ493E3DA002, MQ493E3E2001, MQ493E3E2002, MQ493E3E1001, MQ493E3DC001, MQ493E3D9001, MQ493E3D4005, MQ493E3D7001, MQ493E3DB002, MQ493E3D2002, MQ493E3D4001, MQ493E3D7002, MQ493E3D4003, MQ493E3D4004, MQ493E3D2001, MQ493E3D8001, MQ493E3D5002, MQ493E3DB001, MQ493E3D2003, MQ493E3DA001, MQ493E3D6001, MQ493E3E1003

Other Recalls from SHIMADZU CORPORATION MEDICAL SYSTEMS ...

Recall # Classification Product Date
Z-0499-2026 Class II Ceiling Type X-Ray Tube Support Models CH-200 a... Oct 16, 2025
Z-0316-2025 Class II SONIALVISION G4 is a multi-purpose X-ray R/F sy... Sep 6, 2024
Z-0139-2025 Class II Trinias unity, Digital Angiography System with ... Sep 6, 2024
Z-1292-2024 Class II Shimadzu, Trinias, Digital Angiography System Jan 29, 2024
Z-2270-2023 Class II Over-Head Ceiling Tube Support, CH-200, CH-200M... Apr 10, 2023

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.